スポンサーリンク
Department Of Bio-medical Engineering Tokai University School Of High-technology For Human Welfare | 論文
- OJ-256 Erythropoietin Prevents Apoptotic Cell Death Through Erythropoietin Receptor-mediated Cytoprotective Signaling Pathways(Growth factor/Cytokine-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OE-056 Erythropoietin Prevents LV Remodeling after Myocardial Infarction through Erythropoietin Receptor-Induced Signaling Pathways in the Heart(Acute myocardial infarction, basic-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-242 Erythropoietin Has an Ischemic Postconditioning-like Effect on Myocardium through a Direct Action on Cardiomyocytes(Myocardial ischemia-reperfusion, basic/clinical-2 (M) OJ41,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeti
- Cardioprotective Effects of Granulocyte Colony-stimulating Factor in Chronic Hibernating Swine Myocardium(Old Myocardial Infarction/Remodeling 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- Beneficial Effects of G-CSF on Coronary Atherosclerotic Lesion in Watanabe Heritable Hyperlipidemic Rabbits(Cardiovascular Pharmacology, Basic/Clinical 1 (H), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- The Direct Effects of G-CSF on Cardioprotection against Ischemia/Reperfusion Injury(Myocardial Ischemia-reperfusion, Basic 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- PPARgamma Ligand Inhibits the Progression of Inflammation in Myosin-induced Autoimmune Myocarditis in Rats (Myocarditis, Basic/Clinical 1 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- G-CSF Prevents Cardiac Remodeling after Myocardial Infarction by Activating Jak/STAT in Cardiomyocytes(Vascular Regeneration (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
- OJ-482 G-CSF Prevents Cardiac Remodeling after Acute Myocardial Infarction in Swine(Old Myocardial Infarction/Remodeling 1 (IHD) : OJ59)(Oral Presentation (Japanese))
- Amelioration of Hypertensive Heart Failure by Amlodipine May Occur via Antioxidative Effects
- PJ-666 In Vivo Evidence for the Role of Tenascin-C in Coronary Atherosclerosis(PJ112,Atherosclerosis (Clinical/Pathophysiology) 2 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- PE-567 Noncholesterol Sterol Levels in Male Patients with Coronary Atherosclerosis(PE095,Atherosclerosis (Clinical/Pathophysiology) (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
- -P564- ELECTRON MICROSCOPIC SYUDY OF MYOCARDITIS PATIENTS:OBSERVATIONS OF MITOCHONDRIAL CYTOCHROME OXIDASE ACTIVITY(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- -1037- RELATIONSHIP BETWEEN DIURNAL PATTERN OF BLOOD PRESSURE AND AUTONOMIC NERVE FUNCTION IN NON-DIPPERS WITH ESSENTIAL HYPERTENSION(PROCEEDINGS OF THE 59th ANNUAL SCIENTIFIC MEETING OF THE JAPANESE CIRCULATION SOCIETY)
- -0012-CLINICAL EFFICACY OF PTCA AND DETECTION OF RESTENOSIS : EVALUATION BY SERIAL BODY SURFACE POTENTIAL MAPPING
- BODY SURFACE POTENTIAL MAPPING IN ANTERIOR MYOCARDIAL INFARCTION : A Longitudinal Study in Acute, Convalescent and Chronic Phases
- PE-359 Cytokine Therapy Prevents Left Ventricular Remodeling And Dysfunction after Myocardial Infarction Through Neovascularization.(Cardiovascular Pharmacology, Basic/Clinical 4 (H) : PE61)(Poster Session (English))
- OJ-446 Cerivastatin inhibits the development of heart failure by reducing cardiac apoptosis and cytokine expression in Dahl rat heart failure model(Heart Failure, Basic 3 (M) : OJ54)(Oral Presentation (Japanese))
- OE-368 Ligand-independent activation of angiotensin II type 1 receptor by mechanical stretch(Cardiac Hypertrophy, Basic and Clinical 1 (M) : OE46)(Oral Presentation (English))
- OE-364 Exercise-induced upregulation of _1-adrenergic receptor is involved in the upregulation of Hsp70 through enhanced activity of ERKs(Cardiac Hypertrophy, Basic and Clinical 1 (M) : OE46)(Oral Presentation (English))
スポンサーリンク